Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 9 December 2008
Vol. 1, Issue 49, p. ec424
[DOI: 10.1126/scisignal.149ec424]


Posttranslational Modifications Lysyl Oxidase: A Matrix Inhibitor of TGF-β

Nancy R. Gough

Science Signaling, AAAS, Washington, DC 20005, USA

Transforming growth factor–β1 (TGF-β1) is abundant in the bone matrix and is an important regulator of bone physiology. TGF-β proteins are stored in the extracellular matrix in a latent complex and released upon various stimuli. Atsawasuwan et al. report that lysyl oxidase (LOX), which is an amine oxidase found in bone matrix, interacts with and inhibits TGF-β1 activity. The two proteins coimmunoprecipitated when coexpressed in a bone-derived osteoblast cell line (MC) and interacted in vitro in glutathione S-transferase pull-down experiments. More important, the endogenous proteins were colocalized in the extracellular matrix of cultured MC cells and were isolated as a complex from bone. Transfection of MC cells with a LOX-V5 fusion protein or exogenous addition of LOX-V5 protein inhibited the phosphorylation of Smad3 in response to the addition of recombinant TGF-β1. Inhibiting lysyl oxidase activity of LOX with β-aminopropionitrile (BAPN) restored TGF-β1–induced Smad3 phosphorylation in cells overexpressing LOX or exposed to exogenous LOX-V5, and transfection of a catalytically inactive mutant LOX also had no effect on TGF-β1 signaling. Finally, knockdown of LOX with silencing RNAs in the MC cells enhanced Smad3 phosphorylation in response to recombinant TGF-β1. Questions remain as to whether TGF-β1 is truly a LOX substrate and, if so, whether the crosslinking of TGF-β1 molecules to each other that would likely result would be reversible. However, these results suggest that phenotypes associated with LOX deficiency, which involve bone abnormalities as well as weak tendon and ligament attachments, may not only arise through the effects of LOX on collagen and elastin crosslinking but also involve aberrant TGF-β1 signaling in bone.

P. Atsawasuwan, Y. Mochida, M. Katafuchi, M. Kaku, K. S. K. Fong, K. Csiszar, M. Yamauchi, Lysyl oxidase binds transforming growth factor-β and regulates its signaling via amino oxidase activity. J. Biol. Chem. 283, 34229–34240 (2008). [Abstract] [Full Text]

Citation: N. R. Gough, Lysyl Oxidase: A Matrix Inhibitor of TGF-β. Sci. Signal. 1, ec424 (2008).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882